Vaccines tested for use against bird flu

Mar 31, 2006

Human testing on a two potential vaccines against the H5N1 strain of bird flu has begun in Germany and Belgium, according to GlaxoSmithKline PLC.

A total of 800 healthy volunteers in Germany and Belgium are being tested to evaluate the vaccines' safety and ability to boost a person's immune response against H5N1, The Wall Street Journal reported Friday.

Health officials worry that the H5N1 bird flu strain could mutate into a strain that would pass easily among humans, causing a pandemic.

The serum being tested in Germany contains an adjuvant -- an agent that modifies the effect of other agents while having few if any direct effects when given by themselves -- that the researchers hope will help stretch the vaccine to a greater number of doses.

In Belgium, Glaxo is testing a vaccine with a newer type of adjuvant it hopes will help protect people against a broader range of H5N1 strains because no one knows which exact form of H5N1 could emerge as the strain that causes a pandemic.

Copyright 2006 by United Press International

Explore further: Dinosaurs fell victim to perfect storm of events, study shows

add to favorites email to friend print save as pdf

Related Stories

The host makes all the difference

Mar 26, 2009

For some people it is a certainty: as soon as the annual flu season gets underway, they are sure to go down with it. It is little comfort to know that there are other people who are apparently resistant to flu or overcome ...

Bird flu spreads into Denmark

Mar 15, 2006

Denmark's government says a strain of the avian flu virus has been found in a wild Danish bird -- the first case of bird flu in that nation.

Recommended for you

Affirmative action elicits bias in pro-equality Caucasians

Jul 25, 2014

New research from Simon Fraser University's Beedie School of Business indicates that bias towards the effects of affirmative action exists in not only people opposed to it, but also in those who strongly endorse equality.

User comments : 0